[1]Locationinpatent:experimentalpartYea,ChristopherM.;Allan,ChristineE.;Ashworth,DoreenM.;Barnett,James;Baxter,AndyJ.;Broadbridge,JaniceD.;Franklin,RichardJ.;Hampton,SallyL.;Hudson,Peter;Horton,JohnA.;Jenkins,PaulD.;Penson,AndyM.;Pitt,GaryR.W.;Rivière,Pierre;Robson,PeterA.;Rooker,DavidP.;Semple,Graeme;Sheppard,Andy;Haigh,RobertM.;Roe,MichaelB.[JournalofMedicinalChemistry,2008,vol.51,#24,p.8124-8134]
[1]CurrentPatentAssignee:TEVAPHARMACEUTICALINDUSTRIESLTD.-WO2020/154581,2020,A1Locationinpatent:Paragraph00106-00108;00113-00114
[1]CurrentPatentAssignee:TEVAPHARMACEUTICALINDUSTRIESLTD.-WO2020/154581,2020,A1Locationinpatent:Paragraph00109-00112
Title: New benzylureas as a novel series of potent, nonpeptidic vasopressin V2 receptor agonists.
Journal: Journal of medicinal chemistry 20081225
Title: Yea CM, et al. New benzylureas as a novel series of potent, nonpeptidic vasopressin V2 receptor agonists. J Med Chem. 2008 Dec 25;51(24):8124-34.